The leukotoxic activity of 31 Actinobacillus actinomycetemcomitans isolates from Brazilian periodontal patients [nine from Localized Juvenile Periodontitis (LJP) patients, 22 from patients with AIDS-associated Necrotizing Ulcerative Periodontitis (AIDS/NUP)], and from the reference strain A. actinomycetemcomitans ATCC43718, were analysed for their cytotoxicity on human monocytes. A cytotoxicity inhibitory assay of the isolate P35 and the reference strain ATCC 43718 with sera from ten LJP patients and ten healthy subjects was also performed and leukotoxin reactivity was evaluated with serum from rabbits immune to leukotoxin from A. actinomycetemcomitans ATCC 43718. The cytotoxicity results were not statistically different among groups of A. actinomycetemcomitans isolates from LJP and AIDS/NUP patients, but the individual analysis of each isolate showed two isolates (P24 and P35) from LJP patients with high leukotoxic activity (P50.05). Also, a high leucotoxic inhibitory effect with LJP patients' sera compared with healthy subjects with sonic extract from isolate P35 (P50.05) and the reactivity of rabbit antiserum to leukotoxin were observed. Both leukotoxic and non-leukotoxic strains of A. actinomycetemcomitans can be isolated from LJP and AIDS/NUP patients, but A. actinomycetemcomitans with high leukotoxic activity is more frequent in PJL than AIDS/NUP patients. Even though A. actinomycetemcomitans exhibits leukotoxic activity, there is an immune response to the leucotoxin in LJP patients.
Introduction
Localized juvenile periodontitis (LJP) is an early-onset form of periodontitis characterized by rapid progres-sion, affecting the first molars and incisors, with a high prevalence of Actinobacillus actinomycetemcomitans [1, 2] and polymorphonuclear leukocyte (PMN) abnormalities [3, 4] . A. actinomycetemcomitans is a Gram-negative, capnophilic, non-motile coccobacillus, separated into ten biotypes [2] and five serotypes a, b, c, d, and e [5] . This organism produces several virulence factors, such as a 115-180 kDa heat-labile leukotoxin. These factors can suppress the host's defense mechanisms [6] , destroying human monocytes, PMN, macrophages, and cell lines such as Jurkat, MOLT-4, Daudi, or Raji [2, 7, 8] . Leukotoxic activity can be observed with sonic extract from A. actinomycetemcomitans when incubated with human monocytes and lactate dehydrogenase (LDH) released from these monocytes [9, 10] . Furthermore, the leukotoxin produces immunosuppression in the host by killing monocytes that might act as antigenpresenting cells in an early immune response phase. It can inhibit blastogenesis and antibodies or cytokines production [11] , which may explain the same antibody levels or cellular immune response in LJP patients and healthy control subjects [11] [12] [13] [14] [15] . On the other hand, the immune response against A. actinomycetemcomitans in LJP patients was detected by others [16, 17] .
Periodontal disease is frequently observed in patients with breakdowns in their defense capacity, such as HIV-positive patients. Severe destructive lesions, spontaneous painful gingival bleeding, and soft tissue necrosis may be observed in HIV-positive patients with associated necrotizing ulcerative periodontitis (AIDS/NUP) [18] . On the other hand, no prevalence of leukotoxic strains of A. actinomycetemcomitans in AIDS/NUP patients has been reported in the literature. This study was carried out to determine the leukotoxic activity of A. actinomycetemcomitans isolated from Brazilian patients with LJP and AIDS/ NUP, using human monocyte cells. Leukotoxin inhibitory activity of serum from LJP patients and leukotoxin reactivity with serum from rabbit immune to leukotoxin from A. actinomycetemcomitans ATCC 43718 were also evaluated.
Material and Methods

Specimens and microorganisms
Supragingival dental plaques were removed from the mesial surface of two periodontally affected teeth using sterile cotton pledgets. Subgingival bacterial samples were obtained by two sterile paper points (Endopoints Ind. Co. Ltd. Paraiba do Sul, RJ, Brazil), Inserted into periodontal pockets of LJP and AIDS/ NUP patients, all aged 15-30 years, from the periodontal Clinic at the State University of Londrina, Londrina, PR, and from the University of São Paulo, SP, Brazil, respectively. All the LJP patients showed clinical and radiographic evidence of alveolar bone loss confined to the first molar or incisor teeth, and periodontal pockets 5 mm or more deep. Subgingival plaque samples were obtained and bacteria were isolated using a selective trypticase soy-serum-bacitracin-vancomycin (TSBV) agar (Difco Laboratories, Detroit, MI, U.S.A.) [19] , incubated anaerobically (90% N 2 þ10% CO 2 ) at 378C, for 72 h. The isolates identified as A. actinomycetemcomitans showed a star-like inner structure, were Gram-negative, capnophilic, catalasepositive coccobacilli, and fermented glucose, fructose, and mannose but not lactose, starch, sucrose, or trehalose [20] . All isolates were stored in 20% glycerol in liquid nitrogen.
Serum samples
Human sera were collected from ten LJP patients from the periodontology Clinic at the State University of Londrina, Londrina, PR, Brazil, and ten healthy subjects without clinical or radiographic evidence of periodontal disease were used as controls (all 15-30 years of age). None of them showed evidence of systemic disease nor had they received any antibiotic for at least 3 months prior to the sample collection. Informed consent was obtained from all subjects participating in this study.
Sonic extracts from A. actinomycetemcomitans
The A. actinomycetemcomitans isotates were cultured on brain heart infusion (BHI) agar supplemented with 0.5% yeast extract, under anaerobic conditions. The organisms were harvested by centrifugation (Hitachi himac CR21, Japan; 16 0006g, at 48C, 15 min), washed in phosphate-buffered saline (PBS), re-suspended in PBS (25 mg/mL), and sonicated as described by Suzuki et al. [21] . After centrifugation, the supernatant was resuspended in PBS, and the protein concentration was determined using Folin with bovine serum albumin as a standard. All extracts were adjusted at the same protein concentration (1.4 mg/mL), and 1.0 mL aliquots were stored at 7808C until use.
Leukotoxic effects of A. actinomycetemcomitans on human monocytes
Human peripheral blood monocytes from normal adult donors were isolated from heparinized venous blood by centrifugation (3006g, 48C, 30 min) with Histopaque D1076 (Sigma Chemical Co., St. Louis, MO, U.S.A.). The mononuclear cells were aspirated, washed three times in PBS, resuspended in RPMI 1640 complete medium supplemented with a final concentration of 10% fetal calf serum, and incubated in Petri dishes at 378C for 60 min. Non-adherent cells were removed by gently rinsing the plates with warm RPMI 1640 medium. Adherent cells were collected by gently rinsing the plates with PBS and 1% ethylenediaminetetraacetic acid (EDTA), then transferred to tubes and washed three times by centrifugation in Hank's balanced salt solution (HBSS). The cell concentration was adjusted to 2610 6 cells/mL in HBSS, and the percentage of viable cells was determined by trypan blue exclusion (495% viability). Monocyte cells in suspension (150 mL) were exposed to 0.2, 0.35, 0.7, and 1.4 mg protein/mL of sonic extract from ATCC 43718 (150 mL) or sonic extract from each of 31 A. actinomycetemcomitans isolates (720 mg protein/mL) at 378C, for 60 min. Cells were centrifuged (3006g, 48C, 10 min), and the supernatant was tested for LDH activity as a direct indicator of monocyte cell death. The LDH oxidation rate of reduced nicotinamide adenine dinucleotide was measured at 340 nm. LDH activity was determined by using a Cobas Mira Plus automated clinical chemistry system (Roche Diagnostic Systems, La Roche Ltd. Basel, Switzerland), with Roche reagents. LDH values were expressed in international units (IU). As minimal liberation of the LDH from the cells were incubated PBS and as maximal liberation with triton X-100 (0.05%). The results of the duplicate mean of the three experiments were expressed as percentage of cell lysis, in comparison to controls from maximal cell lysis induced with triton X-100 (100%).
Antiserum against leukotoxin from A. actinomycetemcomitans ATCC 43718
Human monocyte cells (26 10 6 cells/mL) isolated as described above, were incubated with sonicated ATCC 43718 strain (1.4 mg/mL protein) at 378C, for 2 h and washed four times in PBS. They were then emulsified in incomplete Freund adjuvant, and three doses each of 700 mL were subcutaneously injected into rabbits at 2 week intervals. Antiserum was secured 2 weeks later and adsorbed with human monocytes cells according to Baehni et al. [9] with modifications.
Neutralization of the leukotoxin activity of A. actinomycetemcomitans by sera from LJP patients or immunized rabbits Sonic extract from the reference strain (100 mL, 720 mg protein/mL) was incubated with 100 mL of each inactivated serum (568C, 30 min) obtained from ten LJP patients, healthy subjects, anti-leukotoxin ATCC 43718, or pre-immunized rabbits (at 378C, 15 min). The monocyte (2610 6 cells/mL) were added and incubated at 378C, for 60 min. Cell lysis was evaluated by LDH dosage, and the results were expressed in IU. As a standard of cellular minimal liberation was incubated with PBS, and as a standard of cellular maximal liberation, with triton X-100 (0.05%).
Double lmmunodiffusion in gel
Six glass slides (2.567.5 cm) were covered with a 3.0 mm thick layer of agar (1% agar, 0.85% NaCl, and 0.02% sodium azide) according to Itano et al. [22] , with seven wells (one central and six peripheral). The immune rabbit serum was applied to the central well, and each sonic extract from A. actinomycetemcomitans (ATCC 43718, P24 and P35) in duplicate with no diluted sample (1.4 mg/mL protein) and 1 : 2 to 1 : 32 dilutions were applied to the peripheral wells. The samples were incubated in a humid chamber at room temperature for 24 h. The gel was washed, dried, and stained with amido black.
Statistical analysis
Data on the leukotoxic effect in sonic extracts from A. actinomycetemcomitans on monocytes were statistically evaluated by the analysis of variance procedure using a randomized complete block design. The sqrt [(1007x) þ 0.5] transformation was applied to the data. The treatment means were compared by the Tukey and Duncan tests at the X% probability level. For leukotoxic neutralization of sonic extracts from A. actinomycetemcomitans using LJP patients' sera, ANOVA Tukey's Studentized Range Test was used (P50.05).
Results
The mean of triplicate LDH values obtained from human monocytes incubated with 100, 175, 350, 700 mg protein of sonic extract from ATCC 43718 were 9.8, 18, 31.3, and 57.8 IU/L, respectively. The values for the controls using PBS and triton X-100 (0.05%) were 2.7 IU and 61 IU, respectively. The final protein concentration (360 mg/mL) to sonic extract from A. actinomycetemcomitans ATCC 43718 was established as 50% (LD50) by correlation with 100% lysis (61 IU), and 57.8 IU corresponding to 700 mg protein/mL as 94.7%.
Analysis of the leukotoxic effect in sonic extracts from A. actinomycetemcomitans on human monocytes
The result of human monocytes % lysis by group of A. actinomycetemcomitans isolated from LJP (24.2%+ 15.9) and from AIDS/NUP (18.9%+3.9) patients was not statistically different (P40.05). The analysis of each sonic extract showed leukotoxic activity with isolates P24 and P35 (22.2%) from LJP (2/9) and isolates A3, A6, A11 and A15 (23.0%) from AIDS/ NUP (4/22) patients and the reference strain, in relation to PBS (P50.05). Isolates P24 and P35 (LJP) and reference strain ATCC 43718 showed higher leukotoxic activity than isolates A3, A6, A7, A11 and A15 (AIDS/NUP) (P50.05; Table 1 ).
Leukotoxic neutralization of sonic extracts from A. actinomycetemcomitans using sera from LJP patients
The neutralization of sera from ten LJP patients and ten healthy subjects was evaluated for the LDH of monocytes used as a response against sonic extracts from ATCC 43718 and P35 isolate. Both strains showed a decreased LDH value when sera from LJP patients were used. However, a significant reduction was observed with P35 isolate (P50.05; Table 2 ).
Leukotoxic neutralization of sonic extract from A. actinomycetemcomitans ATCC 43718 using rabbit anti-leukotoxin ATCC 43718 serum
The results were: 109 IU (pre-immune serum), 12 IU (immune serum), and 45 IU (PBS).
Analysis of sonic extracts from A. actinomycetemcomitans by immunodiffusion in gel
Analysis of sonic extracts from P24, P35 isolates and ATCC 43718 strain with rabbit anti-leukotoxin ATCC 43718 serum by immunodiffusion in gel, showed precipition lines with titre 8.
Discussion
The LDH released activity of the monocytes was used as a direct indicator of monocyte cell death by A. actinomycetemcomitans leukotoxin. The use of this assay with A. actinomycetemcomitans sonic extracts showed leukotoxic activity with isolates P24 and P35 (22.2%) from LJP patients and isolates A3, A6, A11 and A15 (23.0%) from AIDS/NUP patients.
Both leukotoxic and non-leukotoxic strains of A. actinomycetemcomitans can be isolated from LJP patients, however, the percentage of leukotoxic A. actinomycetemcomitans is higher (43-75%) than in healthy people (7%) [2, 6] . Also, in periodontal patients, according to Zambon [2] and Tsai and Taichman [8] , the leukotoxic strains of A. actinomycetemcomitans are characteristically found in young patients, 6 to 13 years old. This may explain our results, since our LJP patients had a mean age of 28 years.
According to Coronado et al. [18] , AIDS/NUP patients may harbour a large number of the periodontal pathogens that are associated with periodontitis in individuals without AIDS. Therefore, early identification and treatment of patients with HIV-associated gingivitis may prevent the rapid and extensive destruction of periodontal tissue. The results of this work also showed the similar % lysis of human 6 cells/mL) were incubated with each tested A. actinomycetemcomitans sonic extract (720 mg protein/mL) or PBS at 378C, for 30 min. The supernatant released LDH was analysed after centrifuging. The LDH oxidation rate of reduced nicotinamide adenine dinucleotide was measured at 340 nm. Results were expressed by percent cell lysis correlates sample levels of LDH to the maximally induced level by using Triton X-100 (100%). monocytes with groups of A. actinomycetemcomitans isolated from LJP and AIDS/NUP patients (P40.05). However only two isolates (P24 and P35) from LJP patients showed higher leukotoxic activity, not observed in isolates from AIDS/NUP patients.
Leukotoxic strains of A. actinomycetemcomitans are capable of killing human monocytes [9] , as well as inhibiting many critical functions of T cells such as blastogenesis and cytokine production [11] , which may inhibit antibody production. However, previous studies have shown high levels of antibodies against A. actinomycetemcomitans [16, 17] . The neutralizing effect of leukotoxic activity from sonic extract of A. actinomycetemcomitans by LPJ patient sera was confirmed, with a significantly higher effect than sera from healthy subjects (P50.05) when using P35 isolate; it can be suggested that antibodies against A. actinomycetemcomitans leukotoxin can be produced by LJP patients. No statistically significant difference between the groups studied was observed with ATCC43718 strain sonic extract, but this may be due to the limited number of samples analysed. However, differences between the leukotoxic activities of P35 isolate and the reference strain, or other serotypes not determined here, can be expected.
The immune response to leukotoxin can also be induced by rabbit immunization with A. actinomycetemcomitans as shown by gel immunodiffusion and by inhibition of the leukotoxic activity of A. actinomycetemcomitans ATCC 43718 strain.
Both leukotoxic and non-leukotoxic strains of A. actinomycetemcomitans can be isolated from LJP and AIDS/NUP patients, but A. actinomycetemcomitans with high leukotoxic activity is more frequent in PJL than AIDS/NUP patients. Even though A. actinomycetemcomitans has leukotoxic activity, there is an immune response to the leucotoxin in LJP patients.
